🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Chronic graft-versus-host disease (cGVHD) is a complication that occurs in ...
Status
Recruiting
Location
The Catholic University of Korea, Seoul St. Mary's Hospital
Start Date
2025-01-15
Trial ID
NCT06756061
Treatments Being Tested
This study will be conducted to determine the preliminary efficacy of axati...
Status
Active Not Recruiting
Location
Mayo Clinic Hospital
Start Date
2024-10-11
Trial ID
NCT06388564
Treatments Being Tested
The goal of this clinical research study is to learn if the combination of ...
Status
Completed
Location
University of Texas MD Anderson Cancer Center
Start Date
2011-09-22
Trial ID
NCT01375140
Treatments Being Tested
To determine the maximum tolerated dose (MTD), if present, and dose schedul...
Status
Unknown
Location
Multiple Locations
Start Date
2018-12-01
Trial ID
NCT03613428
Treatments Being Tested
This is a nonrandomized study of ruxolitinib in combination with a standard...
Status
Completed
Location
The Childrens Hospital of Alabama
Start Date
2016-09-30
Trial ID
NCT02723994
The purpose of the Study is to select a dose and assess the safety and tole...
Status
Terminated
Location
University of Alabama
Start Date
2016-05-18
Trial ID
NCT02711137
Treatments Being Tested
This open-label, non-randomized, phase II exploratory study aims to evaluat...
Status
Recruiting
Location
Blood diseases hospital
Start Date
2026-05-30
Trial ID
NCT07454226
Allogeneic transplant is potentially curative for hematological malignancie...
Status
Recruiting
Location
Univ of Miami - Sylvester Comprehensive Cancer Center
Start Date
2024-12-23
Trial ID
NCT06660355
Treatments Being Tested
This phase II trial studies the side effects and best dose of ruxolitinib p...
Status
Terminated
Location
M D Anderson Cancer Center
Start Date
2015-07-15
Trial ID
NCT02420717
The purpose of this study was to assess the efficacy of ruxolitinib in comb...
Status
Completed
Location
Multiple Locations
Start Date
2016-12-30
Trial ID
NCT02953678
Treatments Being Tested